Clinical Rhabdomyolysis With Acute Kidney Injury Secondary to High-Intensity Rosuvastatin Use: A Case Report

Curēus
Deepak ChitralliKishore Br

Abstract

Statins are the primary class of medication used to lower serum cholesterol concentration for both primary and secondary prevention of cardiovascular disease. Muscle pain is a frequent adverse effect of statins. Severe myonecrosis leading to clinical rhabdomyolysis is rare. We encountered a 63-year-old male with a medical history of hypertension, type 2 diabetes mellitus, and coronary artery disease with angioplasty in 2008 and 2020. He was started on rosuvastatin 40 mg (0-0-1) along with dual anti-platelets post angioplasty and was discharged home. He traveled back to his hometown and noticed progressive symmetric muscle weakness with decreased urine output. After visiting another hospital he presented to us with severe proximal muscle weakness and acute renal failure. Laboratory investigations were initiated which demonstrated clinically significant derangement in serum creatinine phosphokinase, serum creatinine, urine myoglobin along with deranged liver enzymes. He was subjected to nerve conduction studies for his muscle weakness which was normal and electromyography showed abnormal spontaneous muscle activity in all examined muscles (fibrillations, positive sharp waves, and pseudomyotonic discharges) suggestive of an irrita...Continue Reading

References

Oct 2, 2002·Annals of Internal Medicine·Scott M Grundy
Dec 2, 2004·JAMA : the Journal of the American Medical Association·David J GrahamRichard Platt
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
May 6, 2014·Journal of Clinical Lipidology·Terry A Jacobson
Jan 6, 2018·Journal of the American College of Cardiology·Martin Bødtker Mortensen, Erling Falk

❮ Previous
Next ❯

Methods Mentioned

BETA
percutaneous transluminal coronary angioplasty

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Journal of Clinical and Diagnostic Research : JCDR
Kamlesh S SutharHargovind L Trivedi
The Journal of the Association of Physicians of India
Sachinkumar N AmbapkarArpita Dwivedy
The Netherlands Journal of Medicine
F W LeebeekA M Dingemans-Dumas
© 2021 Meta ULC. All rights reserved